References
- 1. Remme WJ, Swedberg K, Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-1560.10.1053/euhj.2001.2783
- 2. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS). Circulation. 1982;66:562-568.10.1161/01.CIR.66.3.562
- 3. Opie LH. The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther. 1994;8(Suppl2):297-304.10.1007/BF00877313
- 4. Brauwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.10.1161/01.CIR.66.6.1146
- 5. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol. 1987;59:23C-30C.10.1016/0002-9149(87)90192-5
- 6. Salerno M, Beller GA. Noninvasive Assessment of Myocardial Perfusion. Circ Cardiovasc Imaging. 2009;2:412-424.10.1161/CIRCIMAGING.109.854893
- 7. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety, and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:595-606.10.1016/S0735-1097(97)00206-4
- 8. Marwick TH. Current status of stress echocardiography for diagnosis and prognostic assessment of coronary artery disease. Coron Artery Dis. 1998;9:411-426.10.1097/00019501-199809070-000049822860
- 9. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34:775-781.10.1093/eurheartj/ehs02222390914
- 10. Camici PG, Prasad SK, Rimoldi OE. Stunning, Hibernation, and Assessment of Myocardial Viability. Circulation. 2008;117:103-114.10.1161/CIRCULATIONAHA.107.70299318172050
- 11. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 1997;30:1693-1700.10.1016/S0735-1097(97)00375-6
- 12. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation. 1973;47:276-286.10.1161/01.CIR.47.2.276
- 13. Schulz R, Heusch G. Hibernating myocardium. Heart. 2000;84:587-594.10.1136/heart.84.6.587
- 14. Bolli R. Myocardial ‘stunning’ in man. Circulation. 1992;86:1671.10.1161/01.CIR.86.6.1671
- 15. Barnes E, Dutka DP, Khan M, Camici PG, Hall RJ. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol. 2002;282:H1603-H1608.10.1152/ajpheart.00786.2001
- 16. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.10.1016/0735-1097(94)90745-5
- 17. Marwick T, D’Hondt A-M, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993;22:159-167.
- 18. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularisation in patients with ischaemic congestive heart failure. J Am Coll Cardiol. 1999;33:1848-1854.10.1016/S0735-1097(99)00102-3
- 19. Kaul S. Assessment of coronary microcirculation with myocardial contrast echocardiography: current and future clinical applications. Br Heart J. 1995;74:490-495.10.1136/hrt.73.6.4904839067626344
- 20. Wei K, Jayaweera AR, Firoozan S, et al. Ultrasound induced microbubble destruction during venous infusion: a novel method in Imaging techniques for the assessment of myocardial hibernation of myocardial blood flow with echocardiography. Circulation. 1998;97:473-483.10.1161/01.CIR.97.5.4739490243
- 21. Meza MF, Ramee S, Collins T, et al. Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function postrevascularization: a study using the combination of myocardial contrast echocardiography and dobutamine echocardiography. Circulation. 1997;96:3459-3465.10.1161/01.CIR.96.10.3459
- 22. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembok IJ, Gimple LV. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.10.1161/01.CIR.89.6.25628205665
- 23. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998;98:1078-1084.10.1161/01.CIR.98.11.1078
- 24. Sutherland GR, Stewart MJ, Groundstroem KWE, et al. Color Doppler Myocardial Imaging: A New Technique for the Assessment of Myocardial function. Journal of the American Society of Echocardiography. 1994;29:A1-A28.
- 25. Di Carli MF, Hachamovitch R. Should PET replace SPECT for evaluating CAD? The end of the beginning. J Nucl Cardiol. 2006;13:2-7.10.1016/j.nuclcard.2005.12.00116464710
- 26. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes. 2002;51:3020-3024.10.2337/diabetes.51.10.302012351442
- 27. Auerbach MA, Schoder H, Hoh C, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 1999;99:2921-2926.10.1161/01.CIR.99.22.2921
- 28. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18-F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 1983;67:766-788.10.1161/01.CIR.67.4.766
- 29. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med. 1986;314:884-888.10.1056/NEJM1986040331414053485252
- 30. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13:24-33.10.1016/j.nuclcard.2005.12.00416464714
- 31. Knaapen P, de Haan S, Hoekstra OS, et al. Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Netherlands Heart Journal. 2010;18:90-98.10.1007/BF03091744282856920200615
- 32. Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int. 2014; 2014:94296033.10.1155/2014/942960403465724901002
- 33. Mori T, Minamiji K, Kurogane H, et al. Rest injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med. 1991;32:1718-1724.
- 34. Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14:521-528.10.1016/j.nuclcard.2007.05.00817679060
- 35. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555-1563.10.2967/jnumed.108.05224118765586
- 36. Hamirani YS, Kramer CM. Cardiac MRI assessment of myocardial perfusion. Future cardiology. 2014;10:349-358.10.2217/fca.14.18415277324976472
- 37. Gerber BL, Raman SV, Nayak K, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Journal of Cardiovascular Magnetic Resonance. 2008;10:18.10.1186/1532-429X-10-18238715518442372
- 38. Nandalur KR, Dwamena BA, Choudri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50:1343-1353.10.1016/j.jacc.2007.06.03017903634
- 39. Morton G, Ishida M, Schuster A, et al. Perfusion cardiovascular magnetic resonance: comparison of an advanced, high resolution and a standard sequence. Journal of Cardiovascular Magnetic Resonance. 2012;9:34.10.1186/1532-429X-14-34340396222682016